drugset / Trial / NCT03580148

BMA vs Cortisone for Glenohumeral Osteoarthritis

NCT03580148

RandomizedParallel-groupOpen-labelTreatment

Summary

This randomized trial seeks to investigate the difference if any between cortisone injection versus bone marrow aspirate injection in the glenohumeral joint of patients with confirmed osteoarthritis. The investigators hope that results from a prospective randomized controlled pilot study on bone marrow aspirate (BMA) glenohumeral joint (GHJ) injections will provide valuable early information on an alternative treatment for GHJ osteoarthritis (OA). This novel study will also contribute clinical data to the growing pool of research around BMA in the treatment of osteoarthritis. This study has the potential to uncover a new and more effective therapy to add to the arsenal of an orthopaedic surgeon in the management of GHJ OA. This would provide improved care and treatment for those disabled by GHJ OA. Additionally, this knowledge would be applicable to a variety of medical practitioners who treat GHJ OA from the general orthopaedic surgeon to pain subspecialists.

Timeline

Start
2015-10-08
Primary completion
2020-07-30
Completion
2021-11-23

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bone Marrow Aspirate Cell therapy 10 ml Other
Comparator Cortisone acetate Other / unclassified 80 mg Other

Indications